Integrating NEU4 and NPL into the TSC1–mTORC1–sialylation axis further refines the mechanistic framework of PD-L1 hypersialylation–driven immune escape, highlighting a coordinated metabolic control of sialic acid turnover in tumor immune regulation. The gene discussed is NEU4; the disease is neoplasm.